| Serial Number | 88204561 |
| Word Mark | SIGNALONE BIO |
| Filing Date | Sunday, November 25, 2018 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, August 29, 2022 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 28, 2019 |
| Pseudo Mark | SIGNAL ONE BIOTECHNOLOGY |
| Disclaimer with Predetermined Text | "BIO" |
| Goods and Services | Pharmaceutical products development; Research and development in the field of oncology; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Research and development services in the field of antibodies; Research in the field of oncology; Research on the subject of pharmaceuticals; Research, development, engineering and testing services in the fields of immunopharmaceuticals and vaccines; Bacteriological research; Biochemical research and development; Biological research; Biomedical research services; Biotechnology research; Chemical, biochemical, biological and bacteriological research and analysis; Clinical research in the field of oncology; Compiling data for research purposes in the field of medical science and medical consultancy; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Development of pharmaceutical preparations and medicines; Laboratory research in the field of oncology; Laboratory research services relating to pharmaceuticals; Medical research; Medical and scientific research in the field of oncology; Medical and scientific research information in the field of cancer; Medical and scientific research in the field of cancer treatment and diagnosis; Medical research services in the field of cancer; Pharmaceutical research and development; Pharmaceutical research services; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Providing medical research and scientific research information in the field of oncology via the Internet; Providing medical testing services and information in the field of cancer research and disease classification; Scientific research; Scientific research and development; Scientific research consulting in the field of oncology; Scientific research for medical purposes in the area of cancerous diseases; Scientific research for medical purposes in the field of cancer; Stem cell research services; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals; Testing, inspection, research, or development of pharmaceutical preparations for gene therapy |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, December 13, 2018 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ElevateBio, LLC |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge, MA 02142 |
| Party Name | ElevateBio, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Cambridge, MA 02142 |
| Event Date | Event Description |
| Monday, August 29, 2022 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, August 29, 2022 | ABANDONMENT - NO USE STATEMENT FILED |
| Saturday, January 8, 2022 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, January 7, 2022 | SOU EXTENSION 5 GRANTED |
| Tuesday, January 4, 2022 | SOU EXTENSION 5 FILED |
| Tuesday, January 4, 2022 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, July 21, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 19, 2021 | SOU EXTENSION 4 GRANTED |
| Monday, July 19, 2021 | SOU EXTENSION 4 FILED |
| Monday, July 19, 2021 | SOU TEAS EXTENSION RECEIVED |
| Thursday, June 10, 2021 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, June 10, 2021 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Thursday, June 10, 2021 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Saturday, March 6, 2021 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, March 5, 2021 | SOU EXTENSION 3 GRANTED |
| Monday, January 25, 2021 | SOU EXTENSION 3 FILED |
| Tuesday, March 2, 2021 | NOTICE OF REVIVAL - E-MAILED |
| Monday, March 1, 2021 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Monday, March 1, 2021 | PETITION TO REVIVE-GRANTED |
| Monday, March 1, 2021 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, March 1, 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, March 1, 2021 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, September 1, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, August 31, 2020 | SOU EXTENSION 2 GRANTED |
| Thursday, July 23, 2020 | SOU EXTENSION 2 FILED |
| Tuesday, August 25, 2020 | NOTICE OF REVIVAL - E-MAILED |
| Monday, August 24, 2020 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Monday, August 24, 2020 | PETITION TO REVIVE-GRANTED |
| Monday, August 24, 2020 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, August 24, 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, August 24, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| Friday, March 27, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, March 26, 2020 | SOU EXTENSION 1 GRANTED |
| Thursday, January 23, 2020 | SOU EXTENSION 1 FILED |
| Wednesday, March 25, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Monday, March 2, 2020 | NOTICE OF REVIVAL - E-MAILED |
| Saturday, February 29, 2020 | SOU EXTENSION RECEIVED WITH TEAS PETITION |
| Saturday, February 29, 2020 | PETITION TO REVIVE-GRANTED |
| Saturday, February 29, 2020 | TEAS PETITION TO REVIVE RECEIVED |
| Monday, February 24, 2020 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Monday, February 24, 2020 | ABANDONMENT - NO USE STATEMENT FILED |
| Tuesday, July 23, 2019 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, July 22, 2019 | ASSIGNED TO EXAMINER |
| Tuesday, May 28, 2019 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 28, 2019 | PUBLISHED FOR OPPOSITION |
| Wednesday, May 8, 2019 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, April 24, 2019 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Monday, April 22, 2019 | ASSIGNED TO LIE |
| Tuesday, April 9, 2019 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, February 13, 2019 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, February 12, 2019 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, February 12, 2019 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, February 1, 2019 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, February 1, 2019 | NON-FINAL ACTION E-MAILED |
| Friday, February 1, 2019 | NON-FINAL ACTION WRITTEN |
| Monday, January 28, 2019 | ASSIGNED TO EXAMINER |
| Thursday, December 13, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, November 28, 2018 | NEW APPLICATION ENTERED |